Sterling Biotech Ltd.
NSE: STERLINBIO | BSE: 512299
₹0.70
₹0.00 (0.00%)As on 05-Nov-2018IST
Market cap
₹21 Cr
Revenue (TTM)
₹457 Cr
P/E Ratio
--
P/B Ratio
-0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-19 Cr
-
ROE
-2.2 %
-
ROCE
-0.7 %
-
Industry P/E
39.7
-
EV/EBITDA
382.7
-
Debt to Equity
0
-
Book Value
₹1.4
-
EPS
₹-0
-
Face value
1
-
Shares outstanding
272,170,388
10 Years Aggregate
CFO
₹356.60 Cr
EBITDA
₹246.51 Cr
Net Profit
₹3,348.18 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sterling Biotech
| -82.1 | 0.0 | -36.4 | -80.6 | -48.2 | -33.5 | -42.7 |
|
BSE Sensex*
| -12.3 | -3.9 | -6.2 | -8.3 | 5.9 | 7.3 | 10.7 |
|
BSE Healthcare#
| 8.0 | 3.6 | 8.8 | 9.9 | 24.9 | 13.6 | 12.0 |
|
Company
|
2017
|
2016
|
2015
|
2014
|
|---|---|---|---|---|
|
Sterling Biotech
| 9.9 | -52.3 | 0.7 | -19.2 |
|
BSE Sensex
| 27.9 | 1.9 | -5.0 | 29.9 |
|
BSE Healthcare
| 0.5 | -12.9 | 15.1 | 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sterling Biotech
|
0.7 | 21.0 | 456.9 | -19.3 | -- | -2.2 | -- | 0.0 |
| 3,328.3 | 27,250.0 | 1,339.4 | 356.4 | 33.2 | 23.2 | 76.5 | 16.5 | |
| 431.1 | 16,486.7 | 2,268.6 | 150.1 | 10.6 | 5.4 | 92 | 4.2 | |
| 789.9 | 19,566.0 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.9 | 3.8 | |
| 893.4 | 16,006.2 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 11.3 | 1.7 | |
| 1,789.7 | 20,522.2 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.5 | |
| 166.8 | 22,200.2 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.7 | |
| 1,202.5 | 19,881.5 | 1,284.3 | 134.4 | -- | 30.7 | 80.6 | 15.4 | |
| 434.3 | 17,527.3 | 3,738.7 | 316.7 | 12.5 | 7.5 | 55.3 | 3.6 | |
| 1,920.9 | 31,200.9 | 3,373.0 | 199.0 | 12.6 | 5.9 | 146.5 | 6.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Sterling Biotech
Manufacture of gelatine and its derivatives, resinoids, glues, prepared adhesives, including rubber-based glues and adhesives
-
Incorporated
1985
-
Chairman
--
-
Managing Director
--
-
Group
Sandesara
-
Headquarters
Mumbai, Maharashtra
-
Website
Annual Reports
FAQs for Sterling Biotech
What is the current share price of Sterling Biotech Ltd Today?
The share price of Sterling Biotech Ltd is ₹0.70 (NSE) and ₹0.77 (BSE) as of 05-Nov-2018 IST. Sterling Biotech Ltd has given a return of -48.25% in the last 3 years.
What is the current PB & PE ratio of Sterling Biotech Ltd?
Since, TTM earnings of Sterling Biotech Ltd is negative, P/E ratio is not available.
The P/B ratio of Sterling Biotech Ltd is -0.01 times as on 05-Nov-2018, a 100 discount to its peers’ median range of 3.72 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2018
|
0.00
|
0.16
|
|
2017
|
0.00
|
0.09
|
What is the 52 Week High and Low of Sterling Biotech Ltd?
The 52-week high and low of Sterling Biotech Ltd are Rs -- and Rs -- as of 07-Jun-2026.
What is the market cap of Sterling Biotech Ltd?
Sterling Biotech Ltd has a market capitalisation of ₹ 21 Cr as on 05-Nov-2018. As per SEBI classification, it is a company.
Should I invest in Sterling Biotech Ltd?
Before investing in Sterling Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.